Janssen Scientific Affairs, Llc

This large registry study follows over 15,000 people with psoriasis who are receiving various treatments, including biologic drugs like infliximab, ustekinumab, and guselkumab. The main goal is to monitor the long-term safety and side effects of these medications in real-world se…